Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Philippines Tuberculosis Diagnostics market was valued at USD 433.09 Million in 2025 and is expected to grow at a CAGR of 5.10%, reaching USD 712.21 Million by 2035. The market growth is driven by the development of next-generation molecular diagnostic assays, integration of automated sample preparation and multiplex PCR technologies, expansion of decentralized testing networks, deployment of portable point-of-care diagnostic platforms, improved access to rapid drug-resistance testing, and public–private partnerships.

Key Market Trends and Insights

  • By diagnostics, molecular diagnostics are likely to lead the market in the forecast period.
  • By disease type, the latent tuberculosis diagnostics segment held around 40% market share in the historical period.
  • By end user, diagnostic laboratories led the market in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 433.09 Million
  • Projected Market Size (2035): USD 712.21 Million
  • CAGR (2026-2035): 5.10%

Compound Annual Growth Rate

5.1%

Value in USD Million

2026-2035


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Philippines Tuberculosis Diagnostics Market Overview

Tuberculosis diagnostics refers to the range of medical tests, laboratory techniques, and diagnostic technologies used to detect Mycobacterium tuberculosis (M. tuberculosis), the bacterium responsible for tuberculosis. The market was valued at USD 433.09 Million in 2025, driven by the high burden of tuberculosis, increasing incidence of drug-resistant TB, government-led TB elimination initiatives, rising investments in public healthcare infrastructure, growing adoption of rapid molecular diagnostic technologies, expanding access to point-of-care testing, increased screening among high-risk populations, and rising demand for early diagnosis, accurate detection, and drug-resistance profiling.

Philippines Tuberculosis Diagnostics Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Government-led screening expansion

WHO and the Philippine DOH planned to screen 12 million Filipinos by 2026, alongside a proposed PHP 4.2 billion TB-services budget.

Market Restraints

Limited laboratory resources and supply-chain disruptions

RITM reported delays in TB culture and drug-susceptibility testing in January 2026, while WHO identified diagnostic disruptions following USAID funding cuts.

Market Opportunities

Government-funded molecular testing expansion

In September 2025, the Philippine Health Technology Assessment Division reported government financing approval for cartridge-based and chip-based RT-PCR tests for tuberculosis.

Philippines Tuberculosis Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Philippines Tuberculosis Diagnostics Market Growth Drivers

Government-Led Screening Expansion and Adoption of Molecular Testing is Likely to Enhance the Market Value

The expansion of government-led tuberculosis screening and adoption of advanced diagnostic technologies are supporting market growth in the Philippines. On November 12, 2025, WHO and the Department of Health (DOH) announced plans to screen 12 million Filipinos by 2026, alongside a proposed increase in the 2026 TB-services budget to PHP 4.2 billion. Separately, on May 6, 2026, WHO and the Stop TB Partnership published a toolkit supporting decentralized molecular TB testing through near point-of-care nucleic acid amplification tests and tongue-swab testing. These initiatives can strengthen diagnostic accessibility and increase demand for TB testing technologies.

Philippines Tuberculosis Diagnostics Market Restraints

Procurement Delays and Diagnostic Supply-Chain Disruptions to Constrain the Market Growth

Public-sector resource limitations and disruptions in diagnostic supply chains constrain the expansion of tuberculosis diagnostic services in the Philippines. In January 2026, the Research Institute for Tropical Medicine (RITM) reported delays in TB culture and drug-susceptibility testing due to limited resources. Similarly, WHO's 2025 assessment highlighted disruptions at partner-supported diagnostic sites following USAID funding cuts. These challenges reduce effective laboratory throughput, weaken instrument utilization and increase operating uncertainty, discouraging sustained investment in molecular testing capacity.

Philippines Tuberculosis Diagnostics Market Opportunities

Expansion of Government-Funded Molecular Testing and Decentralized Diagnostics to Boost the Market Demand

The expansion of affordable molecular testing and decentralized diagnostic services presents an opportunity to improve tuberculosis (TB) detection across the Philippines, particularly in underserved areas. In September 2025, the Philippine Health Technology Assessment Division reported government approval of financing for cartridge-based and chip-based RT-PCR tests for drug-susceptible and drug-resistant TB. Such developments could support wider diagnostic access and future market demand.

Philippines Tuberculosis Diagnostics Market Trends

The market is witnessing several key trends including the growing adoption of rapid molecular testing, expansion of decentralized tuberculosis screening, and increasing emphasis on early detection and drug-resistance diagnosis.

Shift Toward Rapid Molecular Testing and Decentralized Screening

The market is supported by continued emphasis on molecular testing for early and accurate TB detection. In December 2025, the Philippine Department of Health reiterated Xpert MTB/RIF as the primary diagnostic test for all presumptive TB cases under Department Circular DC 2024-0212. This policy reinforces the role of molecular diagnostics in national testing pathways and supports demand for diagnostic platforms and related consumables across the country's healthcare system.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Philippines Tuberculosis Diagnostics Market Share

Latent Tuberculosis Diagnostics is Likely to Maintain a Leading Market Position by Disease Type

The market is segmented by disease type into pulmonary tuberculosis diagnostics, extrapulmonary tuberculosis diagnostics, and latent tuberculosis infection diagnostics. Among these, latent tuberculosis diagnostics is expected to maintain a leading position, supported by increasing emphasis on early identification of TB infection and preventive treatment among high-risk populations. The growing focus on tuberculosis elimination programs and systematic screening is expected to strengthen demand for latent TB testing, supporting the segment's market position throughout the forecast period.

Leading Players in the Philippines Tuberculosis Diagnostics Market

The key features of the market report include strategic initiatives by leading players. The major companies in the market are as follows:

QIAGEN N.V.

QIAGEN develops molecular diagnostic technologies, sample preparation systems, and nucleic acid testing solutions. Its portfolio includes the QIAstat-Dx and QIAsymphony platforms, alongside assays for infectious disease detection. The company supports tuberculosis diagnosis through molecular testing and sample processing technologies, serving clinical laboratories, hospitals, and public health institutions across international markets.

Cepheid

Cepheid, a subsidiary of Danaher Corporation, specializes in automated molecular diagnostic systems based on its GeneXpert platform. Its tuberculosis portfolio includes Xpert MTB/RIF and Xpert MTB/RIF Ultra assays, which detect Mycobacterium tuberculosis and identify genetic markers associated with rifampicin resistance. Its technologies support rapid TB diagnosis across hospitals, laboratories, and decentralized healthcare settings.

Molbio Diagnostics Private Limited

Molbio Diagnostics is an Indian molecular diagnostics company known for its Truenat platform, a portable, chip-based real-time PCR system. Its tuberculosis portfolio includes Truenat MTB, MTB Plus, and MTB-RIF Dx assays. These technologies enable decentralized TB testing and drug-resistance detection, supporting national tuberculosis control programmes and diagnostic access in resource-limited settings.

F. Hoffmann-La Roche Ltd.

Roche develops molecular diagnostic technologies, laboratory automation systems, and infectious disease testing solutions. Its diagnostic portfolio includes PCR-based platforms and assays used for detecting infectious pathogens. Through its molecular diagnostics capabilities, the company participates in the broader tuberculosis diagnostic ecosystem, supporting clinical laboratories and healthcare institutions with automated testing infrastructure.

Other key players in the market include Abbott, Becton, Dickinson and Company (BD), FUJIFILM Holdings Corporation, Eiken Chemical Co., Ltd., Qure.ai Technologies Private Limited, and Hain Lifescience GmbH.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Philippines Tuberculosis Diagnostics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Diagnostics

  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological and Antigen-Based Tests
  • Drug Susceptibility Testing

The market is segmented by diagnostic technology, covering conventional microscopy and culture-based methods alongside rapid molecular assays and immunological tests. Increasing adoption of nucleic acid amplification technologies, automated testing platforms, and molecular drug-resistance detection supports improvements in diagnostic accuracy, turnaround time, and access to TB testing.

Market Breakup by Disease Type

  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection

The market is categorized by disease type into pulmonary, extrapulmonary, and latent tuberculosis diagnostics. Demand is supported by the substantial burden of pulmonary TB, the need to identify infections affecting extrapulmonary sites, and expanded screening among high-risk populations. Improved molecular testing capabilities are also strengthening diagnostic approaches for different TB presentations.

Market Breakup by End User

  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others

The segment comprises hospitals, diagnostic laboratories, research laboratories, and other healthcare facilities. Hospitals contribute through patient screening, clinical diagnosis, and treatment monitoring, while diagnostic laboratories support specialized molecular testing, microscopy, culture, and drug-susceptibility analysis. Government TB programmes and expanding diagnostic networks further support institutional demand for tuberculosis testing services.

Key Questions Answered in the Philippines Tuberculosis Diagnostics Market Report

  • What was the Philippines tuberculosis diagnostics market value in 2025?
  • What is the Philippines tuberculosis diagnostics market forecast outlook for 2026-2035?
  • What are the major factors aiding the Philippines tuberculosis diagnostics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major Philippines tuberculosis diagnostics market trends?
  • Which diagnostics is expected to dominate the market segment?
  • Which disease type is projected to lead the market segment?
  • Which end user is anticipated to drive the market segment?
  • Who are the key players involved in the Philippines tuberculosis diagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a structured mixed-methods research approach combining secondary research, market analysis, and data validation:

  • Primary Research: Insights from tuberculosis specialists, pulmonologists, infectious disease physicians, diagnostic laboratory professionals, procurement managers, and public health experts involved in tuberculosis screening and diagnosis in the Philippines.
  • Secondary Research: Information from the World Health Organization (WHO), Philippine Department of Health (DOH), National Tuberculosis Control Program (NTP), Research Institute for Tropical Medicine (RITM), Philippine Health Technology Assessment Division (HTAD), and ClinicalTrials.gov. Company websites and product documentation from QIAGEN, Cepheid, Molbio Diagnostics, Roche, Abbott, and BD are also considered for product portfolios, diagnostic technologies, and company developments.
  • Validation: Market estimates and qualitative findings are assessed through source triangulation, top-down and bottom-up market analysis, and consistency checks to ensure reliability and relevance to the Philippines tuberculosis diagnostics market.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnostics
  • Disease Type
  • End User
Breakup by Diagnostics
  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological & Antigen-Based Tests
  • Drug Susceptibility Testing
Breakup by Disease Type
  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection
Breakup by End User
  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Abbott
  • Becton, Dickinson and Company (BD)
  • Qiagen N.V.
  • FUJIFILM Holdings Corporation
  • Cepheid
  • Molbio Diagnostics Private Limited
  • Hain Lifescience GmbH
  • Eiken Chemical Co., Ltd.
  • Qure.ai Technologies Private Limited
  • F. Hoffmann-La Roche Ltd.

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us